ATC Group: N01BB09 Ropivacaine

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of N01BB09 in the ATC hierarchy

Level Code Title
1 N Nervous system
2 N01 Anesthetics
3 N01B Anesthetics, local
4 N01BB Amides
5 N01BB09 Ropivacaine

Active ingredients in N01BB09

Active Ingredient

Ropivacaine is a long-acting amide-type local anaesthetic with both anaesthetic and analgesic effects. At high doses ropivacaine produces surgical anaesthesia, while at lower doses it produces sensory block with limited and non-progressive motor block.

Related product monographs

Document Type Information Source  
 NAROPIN Solution for injection MPI, US: SPL/Old FDA, National Drug Code (US)
 ROPIVACAINE Solution for infusion MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)

Medicines in this ATC group

United States (US)

Austria (AT)

Brazil (BR)

Canada (CA)

France (FR)

Hong Kong (HK)

Ireland (IE)

Japan (JP)

New Zealand (NZ)

Poland (PL)

Singapore (SG)

South Africa (ZA)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.